Initiative for Development of Novel Biomarkers in Immune Neuropathies
- Conditions
- Chronic Inflammatory Demyelinating PolyneuropathyG61.8Other inflammatory polyneuropathies
- Registration Number
- DRKS00010596
- Lead Sponsor
- niversitätsklinkium Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Fulfil the diagnostic criteria for CIDP of the Joint Task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. 2. IVIG therapy.
Exclusion Criteria
1. Below the age of 18. 2. Pregnancy.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of clinical parameters, autoantibodies and biomarkers to predict the disease course and outcome of chronic inflammatory demyelinating polyneuropathy in (CIDP) as quick as possible and with maximum safety.
- Secondary Outcome Measures
Name Time Method